San Juan, Argentina.- In the photos taken on July 18, 2023, health professionals participate in a vaccination day. The research team that develops the ARVAC vaccine, Cecilia Grierson, reported that it has completed the phase 3 clinical trial and will present the corresponding information to the ANMAT to continue the evaluation process and the next steps towards the eventual approval of the vaccine.

America , Argentina , coronavirus , Latin America , COVID-19 , Covid-19 vaccine